Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity
about
Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugsCellular and molecular mechanisms underlying oxygen-dependent radiosensitivityEvidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinomaCombinatorial control of transgene expression by hypoxia-responsive promoter and microrna regulation for neural stem cell-based cancer therapy.Anti-cancer stemness and anti-invasive activity of bitter taste receptors, TAS2R8 and TAS2R10, in human neuroblastoma cells.Hypoxia and regulation of cancer cell stemness.Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.Highly specific targeting and imaging of live cancer cells by using a peptide probe developed from rationally designed peptides.Prostate cancer cell lines under hypoxia exhibit greater stem-like properties.Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells.β-carotene Regulates the Murine Liver Microenvironment of a Metastatic Neuroblastoma.Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells.The effects of nutrient depleted microenvironments and delta-like 1 homologue (DLK1) on apoptosis in neuroblastoma.MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC).The Ca2+/calmodulin-dependent protein kinase kinase, CaMKK2, inhibits preadipocyte differentiation.Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomasDLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo.Sasa quelpaertensis Leaf Extract Inhibits Colon Cancer by Regulating Cancer Cell Stemness in Vitro and in Vivo.Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.ING1b negatively regulates HIF1α protein levels in adipose-derived stromal cells by a SUMOylation-dependent mechanismHypoxia and TGF-β1 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumorsAn ornamental plant targets epigenetic signaling to block cancer stem cell-driven colon carcinogenesis.Cancer stem cells and chemoresistance: The smartest survives the raidRAP80 regulates epithelial-mesenchymal transition related with metastasis and malignancy of cancer.Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics.Walnut Phenolic Extract and Its Bioactive Compounds Suppress Colon Cancer Cell Growth by Regulating Colon Cancer Stemness.Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits.Interaction of delta-like 1 homolog (Drosophila) with prohibitins and its impact on tumor cell clonogenicity.Targeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiationIsolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach.Hypoxia and hypoxia-inducible factors: master regulators of metastasis.Hypoxia-inducible factors: mediators of cancer progression; prognostic and therapeutic targets in soft tissue sarcomas.DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist.Imaging Early Fate of Cancer Stem Cells in Mouse Hindlimbs with Sodium Iodide Symporter Gene and I-124 PET.Morphogen-related therapeutic targets for liver fibrosis.Combination of Sasa quelpaertensis Nakai leaf extract and cisplatin suppresses the cancer stemness and invasion of human lung cancer cells.Mulberry leaf extract inhibits invasive potential and downregulates hypoxia-inducible factor-1α (HIF-1α) in SK-N-BE2C neuroblastoma cells.FoxM1 in tumorigenicity of the neuroblastoma cells and renewal of the neural progenitors.Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma.
P2860
Q26777335-CF42BA80-F3FD-4253-B7CA-A169157A3A62Q28087499-EF2E40F1-D7D6-4C82-A709-F58C309491A9Q28478709-82E3724C-19E2-41E7-9917-0BBBE59D0E37Q33594142-FA83436C-F3C3-4498-830D-301A090EF47EQ33632351-5805D994-841D-414E-AD3A-52B54A50C73CQ33705149-7199B53F-E8A1-43BF-969C-1CFA0C923B34Q33779474-8449C276-4904-4A44-AF1E-92189BB59288Q33889674-43CA824E-ED96-4798-A008-5ADFC78D1426Q34117287-1DCCEB92-6663-4B91-A603-DB558AB3142BQ34170335-F1A0A2E8-51B4-4705-AFB0-6D479131B6C1Q34305289-80506D11-A2E6-486D-8C69-96272A332AAEQ34480664-82F928FA-0639-419C-8A67-448D9E607D88Q34534372-E2B0B601-8289-41EA-B593-11FD2D733F8CQ34552896-A9D7714E-ABFD-402A-B3E1-4915D00025BBQ34671206-23D067AA-A2E2-4B47-A19D-B3C61FF4CC09Q35223024-B82CDBE6-842A-4A0C-8F0F-E546667D92B7Q35235761-53C93468-5E24-4CFB-8ECC-22356357E51BQ35624893-1A8EF269-BD0D-4752-92E1-FDD783402A3BQ35723100-76C460ED-4F9E-45F8-BA78-B76DF2C1A383Q35880000-C8B692D0-E7C4-4CA0-9BC9-0AB730B5A361Q36347178-E1EE9CA2-74CD-4CEE-B3B4-108752D85B6DQ36401950-734D1DD5-8FFA-4C54-BBA1-AA1A251082C2Q36725991-2C902A6C-6325-41B5-92F9-36090B71E723Q36730432-7934DD0D-39B5-4B0A-938D-A40AC2F05CD6Q36746310-2635D829-D709-4698-BA9D-695265E505C4Q36799983-11903577-0AD0-495B-AD2B-DB7C3C2CD8F3Q37133124-A7F33F88-A888-48E0-9B0A-4CAFFABF3C34Q37588253-FCAB6EA6-52CD-4FA4-9005-CFF00F6CE477Q37625410-2090D1E5-4857-4E32-9135-2A95BE3A8D98Q37687639-4050A9E6-E1F2-4628-AF62-6F74B8B3567CQ37704785-952A8D91-4ED5-4DB5-9F18-E111C248D149Q37801762-B2BA8B3C-29F7-46F3-8082-F4286BCA869AQ38161730-62CA5B93-AC23-42BD-BA41-603818138B07Q38237444-1F4D43A8-A3E6-4E5A-B636-5A06887C5FA2Q38416836-288D6F64-C409-48D5-860A-7B84EA868F09Q38553312-CD8D26AC-F54F-4ABB-BA9A-A9AF99577E1EQ38994079-2133AD52-2F27-44A8-8384-2459D3036FB1Q39170041-A5817727-CA4E-4C01-84D1-7EBB934AA56AQ39555641-281A4430-4B43-41EF-96F9-82357B81570BQ40895976-87903DEC-E84C-4C05-B65F-E8E860B40F7E
P2860
Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity
@ast
Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity
@en
type
label
Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity
@ast
Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity
@en
prefLabel
Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity
@ast
Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity
@en
P2093
P2860
P1433
P1476
Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity
@en
P2093
Daniel Zelterman
P2860
P304
P356
10.1158/0008-5472.CAN-09-1605
P407
P577
2009-12-01T00:00:00Z